Surgery Partners Stock Plunges 39% as Irenic Capital Slashes Stake

Key Facts

1Irenic Capital sold 1,047,583 shares of Surgery Partners during the fourth quarter.

2The transaction value was estimated at approximately $19.25 million based on average Q4 pricing.

3The fund's position value decreased by $23.19 million by quarter-end due to both sales and price fluctuations.

Surgery Partners (SGRY) shares experienced a massive 39% decline following reports that Irenic Capital significantly reduced its equity stake in the company. During the fourth quarter, the investment fund liquidated approximately 1,047,583 shares of the healthcare services provider. The total value of the transaction was estimated at $19.25 million, based on average pricing throughout the quarter. By the end of the period, the fund's total position value in the company had decreased by $23.19 million due to the combined impact of sales and price fluctuations. This large-scale institutional selling has triggered a sharp sell-off, signaling a potential lack of confidence to the broader market. Investors are now closely monitoring SGRY for signs of stabilization after this substantial institutional exit.